European Medicines Agency

'Take up inclusion of Covishield in vaccination passport with EU': Serum Institute urges Centre

Poonawalla on Monday said he has taken up the issues faced by Indians who have taken the Covishield jab travelling to the EU at the "highest levels"

Denmark, Norway, Iceland suspend use of AstraZeneca's COVID jab over concerns about post-vaccine blood clots

As of 8 March, 22 cases of blood clots had been reported among more than three million people vaccinated in the European Economic Area, the European Medicines Agency said

EU drug regulator approves J&J's one-shot COVID-19 vaccine for adults

The European Medicines Agency said it was recommending the COVID-19 jab for those over 18 “after a thorough evaluation” found it met the criteria for efficacy, safety and quality

Coronavirus Outbreak: Indian firms under scanner for selling fake COVID-19 medicines to European countries

Fraudulent documents and certificates are used to traffic counterfeit products related to coronavirus outbreak.

EU to vote on relocation of two London-based regulatory agencies after Brexit; Milan, Frankfurt lead the race

Fight for some of the most prized spoils of Brexit comes to a climax when 27 EU States pick new host cities for two London-based regulatory agencies

Biotech company, Biocon reports 52 percent annual growth

Biotech major Biocon Ltd on Thursday reported Rs 147 crore consolidated net profit for second quarter (July-September) of fiscal 2016-17, registering 57 per cent annual growth from Rs 97 crore in same period year ago.

Lupin submits fresh studies for two generic drugs suspended by EMA

The Mumbai-based firm along with many other companies had received communication from EMA for suspension of Trimetazidine MR 35 mg and Cefpodoxime 200 mg tablets in January 2015.

First malaria vaccine might be available by October

The first malaria vaccine candidate to reach phase-3 of clinical testing was found to partially protect children against the disease up to four years after vaccination and may be available by as early as October this year, scientists reported.

EU regulator recommends suspension India-tested drugs

The European Medicines Agency said the recommendation was based on findings from an inspection that raised concerns about how GVK conducted studies at the Hyderabad site on behalf of the pharmaceutical companies.